News Announcement

Aurobindo Pharma: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

In compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 we hereby certify that the securities received for the period from April 1 2019 to June 30 2019 for dematerialization have been mutilated and cancelled after due verification. The name of the respective depository has been substituted as the registered owner in respect of those dematerialized equity shares in our records within 15 days of receipt of certificate of securities.

Further the certificates of securities which were dematerialized are listed on the Stock Exchanges where earlier issued securities of the Company were listed.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.